Try our Advanced Search for more refined results
Intellectual Property
-
April 17, 2025
Hyundai Can Seek Atty Fees On Withdrawn Ad Patents
A California federal judge on Thursday declared Hyundai the prevailing party in litigation brought against it by StratosAudio Inc. after the Federal Circuit declared StratosAudio's advertising patents invalid, and said the automaker could file a motion seeking attorney fees on two other patents voluntarily withdrawn from the case.
-
April 17, 2025
AstraZeneca Unit Hit With Antitrust Suit Over Soliris
Not-for-profit insurance company EmblemHealth Inc. has hit an AstraZeneca unit with a proposed class action claiming the subsidiary defrauded the U.S. Patent and Trademark Office to delay generic competition of its blood disorder product Soliris.
-
April 17, 2025
Stites & Harbison Adds 4th Cantor Colburn IP Atty In Conn.
A little over six months after Stites & Harbison PLLC launched its new outpost in Connecticut with a three-attorney team from Cantor Colburn LLP, a fourth lawyer has made the jump to join Stites & Harbison's intellectual property and technology service group in Hartford, the firm has said.
-
April 17, 2025
'Moonshine' Fudge Maker Must Pay Fees For Failed IP Claims
The maker of "Chocolate Moonshine" fudge may have won a trade secrets case against his ex-wife and her new chocolate company, but he must pay the defendants more than $174,000 in attorney fees and costs for his unsuccessful trademark and copyright infringement claims.
-
April 17, 2025
Fed. Circ. Won't Revive Network Tech Patent Suit
The Federal Circuit on Thursday upheld a lower court's finding that Seattle-based technology company F5 did not infringe a patent owned by WSOU Investments LLC covering a network traffic distribution technology.
-
April 17, 2025
Music Royalties Co. Hipgnosis Revives UK Fight With Manilow
British music royalties firm Hipgnosis can forge ahead with its unpaid royalties case against singer Barry Manilow in the U.K., after an appellate panel on Thursday overturned a pause imposed because of parallel proceedings in Los Angeles.
-
April 17, 2025
UK Litigation Roundup: Here's What You Missed In London
The past week in London has seen the producers of West End show "Elf the Musical" face a contract dispute, Korean biotech company ToolGen Inc. bring a fresh patents claim against pharma giant Vertex, and ousted car tycoon Peter Waddell bring a claim against the private equity firm that backed his business. Here, Law360 looks at these and other new claims in the U.K.
-
April 16, 2025
Fed. Circ. Won't Touch Meta's PTAB Win Against Xerox
A Federal Circuit panel on Wednesday quickly and without comment rejected a bid from Xerox Corp. to overturn a Patent Trial and Appeal Board decision in favor of Meta Platforms Inc. that found claims in a message distribution patent are invalid.
-
April 16, 2025
Pa. Poultry Farm's Slaughter Methods Deemed Trade Secrets
The Pennsylvania Superior Court has ruled that an animal rights group cannot force a Lebanon County poultry farm to disclose its chicken slaughtering practices, with the court ruling that the materials sought were confidential trade secrets.
-
April 16, 2025
Ye Says DJ Khalil Is Fishing For Profits In 'Donda' IP Lawsuit
The artist formerly known as Kanye West denied derailing discovery in a lawsuit alleging he stole music from DJ Khalil and three other artists for two tracks on his blockbuster "Donda" album, telling a California federal judge Tuesday that the $50,000 sanctions bid is just a "profit-driven fishing expedition."
-
April 16, 2025
Texas Ranch Neighbor Agrees Not To Use 'Mesa Vista' Name
The owner of a property neighboring the late T. Boone Pickens' luxurious Mesa Vista Ranch hunting estate in the Texas Panhandle has agreed to stop using the name after being sued by the ranch's new owner.
-
April 16, 2025
AlmondNet Sues Amazon Again After $136M Ad IP Victory
AlmondNet Inc. is aiming to expand on the $136 million it already won against Amazon for patent infringement with a new suit in Texas federal court accusing the technology giant of infringing another patent tied to directing television advertisements.
-
April 16, 2025
AT&T Gets $450M 'Twinning' Patent Suit Tossed Again
A New York federal judge has held that it is only fitting that she rule twice on a motion to dismiss a $450 million patent lawsuit against AT&T over so-called twinning phone technology, deciding yet again that the patent is not inventive enough to be worth anything.
-
April 16, 2025
New USPTO Group To Target Fraud In Patent Applications
The U.S. Patent and Trademark Office announced new efforts Wednesday to combat fraudulent patent application activity, such as false signatures on filings and attempts to claim undeserved fee discounts, saying the moves will protect the integrity of the patent system.
-
April 16, 2025
Fed. Circ. Won't Revive MIT Patent In Electric Vehicle Fight
The Federal Circuit on Wednesday refused to revive a technology company's patent covering a wireless charging system created by the Massachusetts Institute of Technology, backing a Patent Trial and Appeal Board finding that the challenged claims were too obvious to warrant patent protection.
-
April 16, 2025
9th Circ. Won't Revive Ex-Beach Boy Guitarist's Royalty Fight
The Ninth Circuit refused to reinstate a former Beach Boys guitarist's suit that sought to revoke his royalty agreements with Universal Music Group since they were based on physical record sales and didn't contemplate the evolution of digital streaming, ruling Wednesday the contracts only paid for physical record sale royalties.
-
April 16, 2025
Greek IT Co.'s Suit Over Leaked Patent Info Gets Tossed
A New York federal judge has tossed a Greece-based technology company's suit alleging Ladas & Parry LLP sent proprietary information to a third party while the company had an attorney-client agreement with the firm.
-
April 16, 2025
Bradley Arant Lands 12-Member Morris Manning IP Team
Bradley Arant Boult Cummings LLP has hired a 12-person intellectual property team from Morris Manning & Martin LLP for its Atlanta office.
-
April 16, 2025
Sterlington Adds Ex-Loeb & Loeb PTAB Trials Head In Calif.
International law firm Sterlington PLLC has added a partner who has guided clients in more than 140 proceedings before the U.S. Patent Trial and Appeal Board, strengthening its intellectual property practice with the former chair of Loeb & Loeb's PTAB trials practice, the firm announced Wednesday.
-
April 16, 2025
Texas Law Firm Hits Rival With Web Search Keywords Suit
Texas personal injury firm Thomas J. Henry Law has claimed in a lawsuit filed in Texas federal court that a Lone Star State competitor is unlawfully capitalizing on his reputation by misdirecting web searches through the purchase of certain search keywords.
-
April 16, 2025
X Corp. On The Hook For $105M In Video IP Row, Jury Finds
X Corp. will have to cough up $105 million after a Dallas jury found Wednesday that it infringed a startup company's video sharing technology, awarding significantly less than the $632 million that the patent owner VidStream LLC had sought.
-
April 16, 2025
NC Hospital Beats Weight Loss Clinic's Trademark Suit
A North Carolina federal judge tossed a Tar Heel State weight loss clinic's trademark infringement suit, calling the clinic's mark "relatively weak" and finding it has "very little similarity" to the purportedly infringing mark used by the hospital and healthcare provider it sued.
-
April 16, 2025
Jack Nicklaus Granted $1M In Damages After NIL Win
Jack Nicklaus was granted $1 million Wednesday by a New York state court judge for damages incurred as a result of a preliminary injunction that prevented the golf legend from signing new commercial deals during now-dismissed litigation over the use of his name, image and likeness.
-
April 15, 2025
Astellas Bladder Drug Patent Survives Following Bench Trial
A Delaware federal judge on Tuesday held that generic-drug makers Lupin and Zydus Pharmaceuticals haven't shown "by clear and convincing evidence" that an Astellas Pharma patent covering the bladder medication Myrbetriq is invalid.
-
April 15, 2025
Biogen, Genentech Head To June Trial Over MS Drug Royalties
A California federal judge on Tuesday denied Biogen's bid for summary judgment in a high-stakes contract fight with Roche Holding AG subsidiary Genentech over patent royalties on multiple sclerosis drug sales, saying during a hearing that there's a material dispute over the contract's language and the case will be tried in June.
Expert Analysis
-
Firms Still Have Lateral Market Advantage, But Risks Persist
Partner and associate mobility data from the fourth quarter of 2024 shows that we’re in a new, stable era of lateral hiring where firms have the edge, but leaders should proceed cautiously, looking beyond expected revenue and compensation analyses for potential risks, say Julie Henson and Greg Hamman at Decipher Investigative Intelligence.
-
The New Playbook For Managing Athlete-Controlled IP
Comparing Luka Dončić's and Lebron James' approaches to establishing and managing their brands highlights a shift toward athlete-controlled IP and some lessons on how players and teams can collaborate to capitalize on athletes' star power, say attorneys at Debevoise.
-
Opinion
We Must Allow Judges To Use Their Independent Judgment
As two recent cases show, the ability of judges to access their independent judgment crucially enables courts to exercise the discretion needed to reach the right outcome based on the unique facts within the law, says John Siffert at Lankler Siffert & Wohl.
-
The Central Issues Facing Fed. Circ. In Patent Damages Case
The en banc Federal Circuit's pending review of EcoFactor v. Google could reshape how expert damages opinions are argued, and could have ripple effects that limit jury awards, say attorneys at McAndrews Held.
-
Series
Performing Stand-Up Comedy Makes Me A Better Lawyer
Whether I’m delivering a punchline on stage or a closing argument in court, balancing stand-up comedy performances and my legal career has demonstrated that the keys to success in both endeavors include reading the room, landing the right timing and making an impact, says attorney Rebecca Palmer.
-
Series
Adapting To Private Practice: From SEC To BigLaw
As I adjusted to the multifaceted workflow of a BigLaw firm after leaving the U.S. Securities and Exchange Commission, working side by side with new colleagues on complex matters proved the fastest way to build a deep rapport and demonstrate my value, says Jennifer Lee at Jenner & Block.
-
China High Court Ruling Could Encourage Antitrust Litigation
Practitioners defending U.S. companies in China should take note of a Chinese Supreme Court ruling that plaintiffs can file suits based on either where the alleged action, or where the result of such action, occurred — which will promote civil litigation by minimizing procedural battles over forum selection, says Yang Yang at Leaqual Law Firm.
-
How Fed. Circ. Ruling Complicates Patent Infringement Cases
The Federal Circuit's decision last month in Kroy IP Holdings v. Groupon may make defending patent infringement claims more challenging, time-consuming and expensive — but it has also complicated similar patent infringement proceedings involving the same patents and their appeals, say attorneys at Norton Rose.
-
Making The Case For Rest In The Legal Profession
For too long, a culture of overwork has plagued the legal profession, but research shows that attorneys need rest to perform optimally and sustainably, so legal organizations and individuals must implement strategies that allow for restoration, says Marissa Alert at MDA Wellness, Carol Ross-Burnett at CRB Global, and Denise Robinson at The Still Center.
-
How Amended Rule 702 Affects Testimony In Patent Litigation
In 2023, Federal Rule of Evidence 702 was amended to address the apparent failure of some courts to prevent unreliable expert evidence from reaching a jury, but a statistical analysis of Daubert decisions in 2022 and 2024 shows that courts remain divided about how to apply consistent evidence standards, say attorneys at Perkins Coie.
-
4 Ways Women Attorneys Can Build A Legal Legacy
This Women’s History Month, women attorneys should consider what small, day-to-day actions they can take to help leave a lasting impact for future generations, even if it means mentoring one person or taking 10 minutes to make a plan, says Jackie Prester, a former shareholder at Baker Donelson.
-
Navigating The Growing Thicket Of 'Right To Repair' Laws
An emerging patchwork of state laws on the right to repair creates tensions with traditional intellectual property and competition principles, so manufacturers should plan proactively for legal disputes and minimize potential for rival third-party repairs to weaponize state laws, say attorneys at Reed Smith.
-
A Judge's Pointers For Adding Spice To Dry Legal Writing
U.S. District Judge Fred Biery shares a few key lessons about how to go against the grain of the legal writing tradition by adding color to bland judicial opinions, such as by telling a human story and injecting literary devices where possible.
-
Preparing For Disruptions To Life Sciences Supply Chains
Life sciences companies must assess how new and escalating tariffs — combined with other restrictions on cross-border activity singling out pharmaceutical products and medical devices — will affect supply chains, and they should proactively prepare for antitrust and foreign direct investment regulatory review processes, say attorneys at Weil.
-
Beware Risks Of Arguing Multiple Constructions In IP Cases
Defendants accused of patent infringement often argue for different, potentially contradictory, claim constructions before district courts and the Patent Trial and Appeal Board, but the board may be clamping down on this strategy, say attorneys at Dechert.